Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

COLGATE-PALMOLIVE ($CL) Releases Q4 2025 Earnings

None

COLGATE-PALMOLIVE ($CL) posted quarterly earnings results for Q4 2025 on Friday, January 30th. The company reported earnings of $0.95 per share, beating estimates of $0.94 by $0.01. The company also reported revenue of $5,230,000,000, missing estimates of $5,271,978,182 by $-41,978,182.

You can see Quiver Quantitative's $CL stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

COLGATE-PALMOLIVE Insider Trading Activity

CL Insider Trades

COLGATE-PALMOLIVE insiders have traded $CL stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CL stock by insiders over the last 6 months:

  • SALLY MASSEY (Chief Human Resources Officer) sold 1,237 shares for an estimated $100,060

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

COLGATE-PALMOLIVE Hedge Fund Activity

We have seen 729 institutional investors add shares of COLGATE-PALMOLIVE stock to their portfolio, and 950 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

COLGATE-PALMOLIVE Congressional Stock Trading

Members of Congress have traded $CL stock 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $CL stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

COLGATE-PALMOLIVE Analyst Ratings

Wall Street analysts have issued reports on $CL in the last several months. We have seen 7 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

  • JP Morgan issued a "Overweight" rating on 12/18/2025
  • RBC Capital issued a "Outperform" rating on 12/09/2025
  • Citigroup issued a "Buy" rating on 11/03/2025
  • UBS issued a "Buy" rating on 11/03/2025
  • Morgan Stanley issued a "Overweight" rating on 11/03/2025
  • Evercore ISI Group issued a "Outperform" rating on 11/03/2025
  • Wells Fargo issued a "Underweight" rating on 11/03/2025

To track analyst ratings and price targets for COLGATE-PALMOLIVE, check out Quiver Quantitative's $CL forecast page.

COLGATE-PALMOLIVE Price Targets

Multiple analysts have issued price targets for $CL recently. We have seen 13 analysts offer price targets for $CL in the last 6 months, with a median target of $88.0.

Here are some recent targets:

  • Andrea Teixeira from JP Morgan set a target price of $93.0 on 01/16/2026
  • Peter Grom from UBS set a target price of $93.0 on 01/14/2026
  • Chris Carey from Wells Fargo set a target price of $86.0 on 01/13/2026
  • Robert Moskow from TD Cowen set a target price of $86.0 on 01/08/2026
  • Michael Lavery from Piper Sandler set a target price of $88.0 on 01/07/2026
  • Nik Modi from RBC Capital set a target price of $88.0 on 12/09/2025
  • Lauren Lieberman from Barclays set a target price of $80.0 on 11/04/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles